MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 164 filers reported holding MERIDIAN BIOSCIENCE INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $113,000 | -18.1% | 11,900 | +2.6% | 0.00% | 0.0% |
Q2 2019 | $138,000 | -82.8% | 11,600 | -71.7% | 0.00% | -85.7% |
Q2 2016 | $800,000 | +323.3% | 41,000 | +256.5% | 0.01% | +250.0% |
Q4 2014 | $189,000 | -16.7% | 11,500 | +4.5% | 0.00% | 0.0% |
Q2 2014 | $227,000 | -22.3% | 11,000 | -18.0% | 0.00% | -50.0% |
Q1 2014 | $292,000 | -27.9% | 13,412 | -28.8% | 0.00% | -33.3% |
Q2 2013 | $405,000 | – | 18,835 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |